Evidence map›Paper›PMID 41462233›Full record

ArticleMicrobial cell factories2025

Kinetic modeling of terpenoid production in E. coli: insights into subpopulation emergence and process optimization.

Prashant Mainali, Naulchan Khongsay, Benjamin Shang Yong Au-Yeung, Congqiang Zhang, Kumar Selvarajoo, Yvonne Chow, Chueh Loo Poh

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Prashant MainaliSingapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR ), 31 Biopolis Way, Nanos, Singapore, Singapore.
Naulchan KhongsaySingapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR ), 31 Biopolis Way, Nanos, Singapore, Singapore.
Benjamin Shang Yong Au-YeungNUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore.
Congqiang ZhangSingapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR ), 31 Biopolis Way, Nanos, Singapore, Singapore.
Kumar SelvarajooNUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore.
Yvonne ChowSingapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR ), 31 Biopolis Way, Nanos, Singapore, Singapore. yvonne_chow@a-star.edu.sg.
Chueh Loo PohDepartment of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore. poh.chuehloo@nus.edu.sg.

Funding

Biotransformation Innovation Platform H20H6a0028
6 · The paper itself

Abstract

Escherichia coli is a promising host for terpenoid production, yet kinetic models tailored for such strains are limited—hindering effective bioprocess optimization and control. To address this, we developed a kinetic model of E. coli engineered to produce viridiflorol, aiming to capture the dynamics of key bioprocess variables under both uninduced and induced conditions. To account for growth and metabolism of cells, a simplified central metabolic pathway of E. coli was considered by including acetyl-CoA as the intracellular metabolite due to its role as a common precursor for viridiflorol, acetate, and the TCA cycle. Initial modeling efforts based solely on metabolism failed to reproduce experimental trends, prompting the inclusion of cellular stress caused by IPTG-induced heterologous pathway activation. However, this adjustment alone could not fully explain the observed trends, leading us to hypothesize the emergence of two distinct subpopulations post-induction: (1) stressed, slow-growing producers and (2) dormant non-producers that eventually outgrow producers. After iterative refinements, the model successfully replicated experimental trends with R2 value for glucose, cells, acetate, dissolved oxygen, and viridiflorol being 0.98, 0.88, 0.86, 0.70, and 0.94 respectively. Finally, model simulations were performed for insights which suggested that lowering IPTG concentration can improve viridiflorol production by delaying the emergence of the non-producer population. Guided by the simulations, an optimal IPTG concentration (9.375 µM) for a batch condition was identified, resulting in a titre of 0.14 g/L of viridiflorol. In contrast, a non-optimal IPTG concentration (150 µM) yielded a titre of only 0.03 g/L. Furthermore, experimental validation of the subpopulation hypothesis showed the coexistence of producer and non-producer populations. Taken together, the model captured the bioprocess variable trends, predicted an optimal IPTG concentration for a batch process, and provided insights into the existence of two subpopulations.

Indexed as

Escherichia coliModels, BiologicalTerpenesGlucoseKineticsMetabolic EngineeringGlucoseTerpenesCellular stressIPTGKinetic modelSimulationSubpopulationsTerpenoids

Identifiers

PMID41462233
PMCPMC12860145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.